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A NOVEL AUTOLOGOUS PLASMA BASED VISCOSUPPLEMENTATION
A. Yayon. Procore Biomed, Nes Ziona, Israel
Purpose: Combined long acting viscosupplement and autologous car-
tilage promoting factors for the treatment of osteoarthritis.
Methods: RegenoGel-SP is a novel elastomer made of ﬁbrinogen
enriched plasma chemically linked to high molecular weight Hyalur-
onic acid (HA). Plasma ﬁbrinogen-HA conjugate solution polymerized
by CaCl2 was seeded with primary human articular chondrocytes. Cell
viability and potency in the 3D constructs were evaluated using Alamar
blue, DMMB for sulphated glycosaminoglycans (sGAGs) and quantita-
tive rtPCR for chondro-speciﬁc markers.
Results: In the last OARSI meeting we presented a novel Fibrin-HA
conjugate as a long acting viscosupplement and as a carrier for the
disease modifying agent FGF18 or its FGF receptor selective variants. To
further enhance the biological properties of the hydrogel, a similar
chemical approach was implemented using whole human plasma
conjugated to high molecular weight Hyaluronic acid. This self plasma
based hydrogel designated Regenogel-SP demonstrated remarkable
physical endurance and biocompatibility to diverse primary cell types.
Speciﬁcally, Regenogel-SP demonstrated superior capacity to support
cell proliferation, viability and differentiation of human articular
chondrocytes from both normal and OA cartilage.
Conclusions:We have previously reported on the regenerative and cell
supportive activity of Fibrin-HA compositions combined with FGF18
variants. The newly developed Regenogel-SP provides a novel and safe
approach for delivering autologous plasma rich constituents in a stable,
long acting, viscous support for cartilage preservation and repair in OA.
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RELATIONSHIP BETWEEN TOE GRIP STRENGTH AND
OSTEOARTHRITIS OF THE KNEE: A PRELIMINARY STUDY
D. Uritani, T. Fukumoto. Kio Univ., Nara, Japan
Purpose: Toe ﬂexor function is important for balancing and walking.
However, we often encounter knee osteoarthritis (OA) patients who
cannot touch their toes to the ground, and therefore, the toes do not
function during walking. We hypothesised that toe function is affected
with knee OA and investigated the relationship between knee OA and
toe grip strength (TGS).
Methods: Seventy-eight knee OA patients (12 men and 66 women;
mean age, 73.5  7.3 years; OA group) and 71 healthy community-
dwelling individuals (13 men and 54 women; mean age, 72.5  5.5
years; control group participated in the study. With regard to Kellgren-
Lawrence grading in the OA group, 8 subjects had grade 2, 32 had grade
3, and 38 had grade 4. The control group comprised individuals without
any pain and knee malalignment, who could walk without aid. The
outcome measures were body mass index (BMI), TGS, and isometric
knee extension strength (IKES). The TGS and IKES were measured twice
using a toe grip dynamometer and hand-held dynamometer, respec-
tively, and the mean values were calculated. Data were collected on the
affected side in the OA group and non-dominant side in the control
group. The dominant foot was identiﬁed as the one preferred for kicking
a ball. Data were compared between the 2 groups using an unpaired t-
test. Moreover, multiple logistic regression analysis was performed. The
independent variable was the group and the dependent variables were
age, sex, BMI, TGS, and IKES. The signiﬁcance level was set at 5%. The
local ethics committee approved the study, and all subjects provided
written informed consent prior to study participation. This study was
supported by JSPS KAKENHI Grant Number 25870971.
Results: The BMI was signiﬁcantly higher in the OA group (25.5  3.5)
compared to the control group (21.7 2.6), whereas the TGS and IKES in
the OA group (7.4  4.2 kg and 15.3  6.9 kg, respectively) were sig-
niﬁcantly lower than in the control group (11.6  5.2 kg and 26.8  7.5
kg, respectively). According to multiple logistic regression analysis, the
sex (odds ratio [OR]: 0.05, 95% conﬁdential interval [95%CI]: 0.01-0.32),
BMI(OR: 1.98, 95% CI: 1.49-2.63) and IKES (OR: 0.71, 95% CI: 0.63-0.80)
were associated with OA.
